Ad is loading...
FDMDF
Price
$0.34
Change
-$0.00 (-0.00%)
Updated
Nov 1 closing price
FSPKF
Price
$20.20
Change
-$0.00 (-0.00%)
Updated
Oct 30 closing price
Ad is loading...

FDMDF vs FSPKF

Header iconFDMDF vs FSPKF Comparison
Open Charts FDMDF vs FSPKFBanner chart's image
4DMEDICAL
Price$0.34
Change-$0.00 (-0.00%)
Volume$1.4K
CapitalizationN/A
Fisher & Paykel Healthcare
Price$20.20
Change-$0.00 (-0.00%)
Volume$100
CapitalizationN/A
FDMDF vs FSPKF Comparison Chart
Loading...
View a ticker or compare two or three
VS
FDMDF vs. FSPKF commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDMDF is a Hold and FSPKF is a Hold.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (FDMDF: $0.34 vs. FSPKF: $20.20)
Brand notoriety: FDMDF and FSPKF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: FDMDF: 100% vs. FSPKF: 53%
Market capitalization -- FDMDF: $156.31M vs. FSPKF: $8.78B
FDMDF [@Medical Specialties] is valued at $156.31M. FSPKF’s [@Medical Specialties] market capitalization is $8.78B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FDMDF’s FA Score shows that 0 FA rating(s) are green whileFSPKF’s FA Score has 1 green FA rating(s).

  • FDMDF’s FA Score: 0 green, 5 red.
  • FSPKF’s FA Score: 1 green, 4 red.
According to our system of comparison, FSPKF is a better buy in the long-term than FDMDF.

Price Growth

FDMDF (@Medical Specialties) experienced а 0.00% price change this week, while FSPKF (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.23%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -6.14%.

Industries' Descriptions

@Medical Specialties (-4.23% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

FUNDAMENTALS
Fundamentals
FSPKF($8.78B) has a higher market cap than FDMDF($156M). FSPKF YTD gains are higher at: 43.161 vs. FDMDF (-37.483). FSPKF has higher annual earnings (EBITDA): 434M vs. FDMDF (-33.73M). FSPKF has higher revenues than FDMDF: FSPKF (1.59B) vs FDMDF (1.38M).
FDMDFFSPKFFDMDF / FSPKF
Capitalization156M8.78B2%
EBITDA-33.73M434M-8%
Gain YTD-37.48343.161-87%
P/E RatioN/A55.87-
Revenue1.38M1.59B0%
Total CashN/A121M-
Total DebtN/A146M-
FUNDAMENTALS RATINGS
FSPKF: Fundamental Ratings
FSPKF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
55
SMR RATING
1..100
81
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
7
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FFEFX16.54-0.07
-0.42%
Nuveen Dividend Value R6
TIHBX12.06-0.06
-0.50%
Transamerica International Stock I
RNWFX80.56-0.79
-0.97%
American Funds New World R5
PEXMX35.67-0.47
-1.30%
T. Rowe Price Extended Equity Market Idx
TEPSX30.61-1.19
-3.74%
ProFunds Technology UltraSector Svc

FDMDF and

Correlation & Price change

A.I.dvisor tells us that FDMDF and FSPKF have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FDMDF and FSPKF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FDMDF
1D Price
Change %
FDMDF100%
N/A
FSPKF - FDMDF
26%
Poorly correlated
N/A
TCHBF - FDMDF
25%
Poorly correlated
N/A
WUXIF - FDMDF
23%
Poorly correlated
N/A
AHICF - FDMDF
15%
Poorly correlated
N/A
NMTC - FDMDF
9%
Poorly correlated
-8.96%
More

FSPKF and

Correlation & Price change

A.I.dvisor tells us that FSPKF and ANSLY have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FSPKF and ANSLY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FSPKF
1D Price
Change %
FSPKF100%
N/A
ANSLY - FSPKF
26%
Poorly correlated
N/A
OLYMY - FSPKF
25%
Poorly correlated
-1.18%
TMDX - FSPKF
25%
Poorly correlated
-8.92%
AXNX - FSPKF
22%
Poorly correlated
N/A
BRSYF - FSPKF
22%
Poorly correlated
N/A
More